Alicn TE-AL-IR2 – Non Contact, Infrared Forehead Thermometer (FDA 510K Cleared)

Description Alicn TE-AL-IR2 – Non Contact, Infrared Forehead Thermometer (FDA 510K Cleared)

• Handheld infrared forehead thermometer
• Non-contact (does not need to be pressed onto skin)
• FDA 510K cleared
• Fast response – one second measurement time
• ±0.4°F accuracy between 95 to 107.6°F

The Alicn TE-AL-IR2 is an FDA 510K cleared, non-contact, forehead thermometer. It features an operating range of 0.6 to 2 inches and does not need to be pressed directly onto skin. The TE-R1B1 is both accurate and fast, performing scans in approximately one second, with ±0.4°F accuracy between 95 to 107.6°F. In higher volume settings, it can keep lines moving, and do so with dependable results.

It features a high temperature alarm to alert personnel when its threshold has been crossed. For example, if the alarm is set for 100 degrees and a subject measures 101, it will alert staff there is an issue. It also contains internal memory for 32 measurements.

Changing Temperature Scales

NOTE REGARDING FDA APPROVAL: The FDA has recently issued guidance providing that it does not object to the distribution and use of telethermographic systems intended for adjunctive diagnostic/initial body temperature assessment and screening during the COVD-19 pandemic where such devices do not create an undue risk. For more information, see https://www.fda.gov/medical-devices/general-hospital-devices-and-supplies/thermal-imaging-systems-infrared-thermographic-systems-thermal-imaging-cameras and https://www.fda.gov/medical-devices/emergency-situations-medical-devices/non-contact-temperature-assessment-devices-during-covid-19-pandemic. We obviously cannot now predict how long the COVID-19 pandemic will last, or what position the FDA may take on such devices in the future. You should always follow all instructions and rules when using any telethermographic system, such as those sold by TEquipment, and should consult with your attorney concerning relevant legal requirements and best practices for implementation and COVID-19 screening.”